Sanger Science

  • 7 October 2025

    In recognition of UK Lupus Awareness Month, we caught up with Catherine Sutherland, Computational Senior Staff Scientist in the Human Genetics programme at the Wellcome Sanger Institute, to discuss more about how their work is contributing to our understanding of lupus.

  • 1 October 202530.2 min read

    Our scientists and collaborators are working together to tackle one of the biggest public health threats: antimicrobial resistance. We are using cutting-edge genomics to hunt down drug-resistant microbes, decode their secrets and stop them in their tracks.

  • Stylised diagram of prime editing in action
    17 July 20239.4 min read

    Prime editing is the latest technique that enables scientists to alter the DNA of a living cell. It builds on CRISPR-Cas9 technology, and offers the potential to edit human cells to treat genetic diseases.

  • 20 June 20237.5 min read

    With a decade of experience turning mosquitoes into genomic data, Alistair Miles is a pillar of the community of entomologists and analysts that keep track of the evolutionary twists and turns of malaria mosquitoes

  • 30 May 202310.4 min read

    An interview with the Sanger Institute’s new director, Matt Hurles.

  • 22 May 20235.8 min read

    Mentoring and training early career scientists; building technology that can adapt to humid and hotter countries; finding a way of transporting anaerobic microorganisms. The pathway to accelerating microbiome research isn’t lacking challenges.

  • 10 May 20236.8 min read

    The human reference genome is the foundation of modern human genetics and genomics, underpinning most research into human health and disease. But, it has limitations - it doesn't reflect human genetic diversity. A new, pangenome reference has now been published, aiming to better represent humanity.

  • 21 April 20236.3 min read

    Every year on April 25th, we observe World Malaria Day to raise awareness and mobilise action against malaria. This year, the World Health Organisation’s call to action focuses on three key areas: investing in the global malaria response, stepping up innovation, and implementing the strategies we have now.